Pan Cancer T was seeded with a €7 Million by Van Herk Ventures, Thuja, Swanbridge Capital and Erasmus MC, O&O Holdings Biotech Health services Pharma Investments 14 September 2023 Share:
Round value (USD): 7.48m Round investors: Thuja Capital Management B.V. Swanbridge Capital Van Herk Ventures Erasmus MC Company: Pan Cancer Industry: Biotech Health services Pharma
Synerkine Pharma in a €5.3M series A extension round led by Fleri, joined by InnovationQuarter Capital, Utrecht Health Seed Fund and Thuja Capital. Biotech Health services Manufacturing Investments 06 October 2023
Anavo scores €8.5M in an equity round backed by Inkef, M Ventures, Taiho Ventures and Bioqube Ventures. Biotech Health services Investments 30 April 2023